Stockscreener 앱 받기
0.51
2.62%
0.013
시간 외 거래:
.53
0.02
+3.92%
전일 마감가:
$0.497
열려 있는:
$0.5102
하루 거래량:
711.86K
Relative Volume:
1.43
시가총액:
$9.36M
수익:
$7.19M
순이익/손실:
$-50.08M
주가수익비율:
-0.00178
EPS:
-286.9
순현금흐름:
$-48.33M
1주 성능:
-14.14%
1개월 성능:
-63.57%
6개월 성능:
-90.96%
1년 성능:
-86.92%
1일 변동 폭
$0.51
$0.5489
1주일 범위
$0.4417
$0.5922
52주 변동 폭
$0.4417
$8.3799
T 2 Biosystems Inc Stock (TTOO) Company Profile
명칭
T 2 Biosystems Inc
전화
781-457-1200
주소
101 HARTWELL AVENUE, LEXINGTON
TTOO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| TTOO | 0.51 | 9.36M | 7.19M | -50.08M | -48.33M | -286.90 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-27 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2019-11-26 | 다운그레이드 | Janney | Buy → Neutral |
| 2019-08-01 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2019-07-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-07-31 | 다운그레이드 | Janney | Buy → Neutral |
| 2019-05-16 | 개시 | Alliance Global Partners | Buy |
| 2019-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-06-01 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-30 | 재확인 | H.C. Wainwright | Buy |
| 2018-05-29 | 재확인 | WBB Securities | Strong Buy |
| 2018-03-29 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-29 | 개시 | Goldman | Neutral |
| 2017-10-18 | 개시 | H.C. Wainwright | Buy |
| 2017-03-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2016-11-10 | 재개 | Leerink Partners | Mkt Perform |
| 2016-11-02 | 재확인 | Cantor Fitzgerald | Buy |
| 2016-07-20 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-06-22 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-04-12 | 재확인 | Canaccord Genuity | Buy |
| 2016-02-17 | 개시 | WBB Securities | Speculative Buy |
모두보기
T 2 Biosystems Inc 주식(TTOO)의 최신 뉴스
T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World
T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey
T2 Biosystems: Q3 Earnings Snapshot - mySA
Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Analysis of ARMISTICE CAPITAL, LLC's Recent Trade in T2 Biosyste - GuruFocus.com
T2 Biosystems Reports Increased Losses and Cash Crunch - TipRanks
T2 Biosystems Inc (TTOO) Quarterly 10-Q Report - Quartzy
T2 Biosystems Announces Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Reports 34% Revenue Growth, Signs Cardinal Health Distribution Deal | TTOO Stock News - StockTitan
T2 Biosystems stock plunges to 52-week low of $0.55 By Investing.com - Investing.com Canada
500: Something went wrong - Investing.com
T2 Biosystems Faces Potential Delisting from Nasdaq due to Market Value - Defense World
T2 Biosystems (TTOO) Scheduled to Post Earnings on Thursday - Defense World
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewswire
T2 Biosystems Forges Sales Deal With Cardinal Health for Sepsis Test - MPO-mag
T2 Biosystems stock plunges to 52-week low of $0.81 - Investing.com
T2 Biosystems stock plunges to 52-week low at $1.08 By Investing.com - Investing.com Australia
T2 Biosystems stock plunges to 52-week low at $1.08 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.37 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.37 By Investing.com - Investing.com UK
T2 Biosystems reports progress in product pipeline By Investing.com - Investing.com South Africa
T2 Biosystems reports progress in product pipeline - Investing.com India
Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships By Investing.com - Investing.com South Africa
Earnings call: T2 Biosystems reports Q3 revenue growth, new partnerships - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.53 - Investing.com
T2 Biosystems stock plunges to 52-week low of $1.53 By Investing.com - Investing.com UK
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems - Yahoo Finance
T2 Biosystems to Host Business Update Call on October 10, 2024 - ForexTV.com
T2 Biosystems and Prxcision announce sepsis solution collaboration By Investing.com - Investing.com South Africa
T2 Biosystems and Prxcision announce sepsis solution collaboration - Investing.com India
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform - The Manila Times
T2 Biosystems, Inc. and Prxcision, Inc. Announce - GlobeNewswire
Market Watch: T2 Biosystems Inc (TTOO)’s Noteworthy Drop, Closing at 1.63 - The Dwinnex
T2 Biosystems reports 35% revenue growth in Q3 - Investing.com
T2 Biosystems reports 35% revenue growth in Q3 By Investing.com - Investing.com South Africa
T2 Biosystems secures exclusive deal with Cardinal Health - Investing.com
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results - The Manila Times
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - The Manila Times
T2 Biosystems secures exclusive deal with Cardinal Health By Investing.com - Investing.com Australia
T2 Biosystems Announces Exclusive U.S. Agreement with - GlobeNewswire
T 2 Biosystems Inc (TTOO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.04%
3.19%
자본화:
|
볼륨(24시간):